Treatment Optimisation for Blood Pressure With Single-Pill Combinations in India (TOPSPIN)
Sponsor: All India Institute of Medical Sciences
Listed as NCT05683301, this PHASE4 trial focuses on Primary Hypertension and remains completed. Sponsored by All India Institute of Medical Sciences, it has been updated 6 times since 2022, reflecting limited change activity. This study contributes longitudinal data to the cardiovascular research landscape.
Status Flow
Change History
6 versions recorded-
Sep 2025 — Present [monthly]
Completed PHASE4
-
Jul 2025 — Sep 2025 [monthly]
Completed PHASE4
-
Nov 2024 — Jul 2025 [monthly]
Completed PHASE4
Status: Active Not Recruiting → Completed
-
Sep 2024 — Nov 2024 [monthly]
Active Not Recruiting PHASE4
Status: Recruiting → Active Not Recruiting
-
Jul 2024 — Sep 2024 [monthly]
Recruiting PHASE4
▶ Show 1 earlier version
-
Feb 2023 — Jul 2024 [monthly]
Recruiting PHASE4
First recorded
Aug 2022
Trial started
Per CT.gov start date — pre-dates our first snapshot
Eligibility Summary
No eligibility information available.
Contact Information
- All India Institute of Medical Sciences
- Centre for Chronic Disease Control, India
- Imperial College London
For direct contact, visit the study record on ClinicalTrials.gov .
Study Locations
Ahmedabad, India , Bangalore, India , Bathinda, India , Bhubaneshwar, India , Bikaner, India , Chennai, India , Devran, India , Dharwad, India , Dibrugarh, India , Ernākulam, India and 17 more locations